NVO logo

Novo Nordisk A/S (NVO) Income Tax

Annual Income Tax

$3.05 B
+$1.13 B+58.81%

31 December 2023

NVO Income Tax Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Income Tax

$1.04 B
+$281.41 M+36.91%

30 September 2024

NVO Quarterly Income Tax Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Income Tax

$3.57 B
+$228.23 M+6.83%

30 September 2024

NVO TTM Income Tax Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NVO Income Tax Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+58.8%+28.0%+37.1%
3 y3 years+81.0%+120.0%+88.5%
5 y5 years+114.1%+266.3%+159.2%

NVO Income Tax High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+81.0%at high+205.6%at high+97.7%
5 y5 yearsat high+114.1%at high+266.3%at high+159.2%
alltimeall timeat high>+9999.0%at high+1329.0%at high+3950.1%

Novo Nordisk A/S Income Tax History

DateAnnualQuarterlyTTM
Sept 2024
-
$1.04 B(+36.9%)
$3.57 B(+6.8%)
June 2024
-
$762.43 M(-19.6%)
$3.34 B(+1.7%)
Mar 2024
-
$948.38 M(+16.2%)
$3.29 B(+7.8%)
Dec 2023
$3.05 B(+58.8%)
$816.43 M(+0.1%)
$3.05 B(+17.0%)
Sept 2023
-
$815.60 M(+15.6%)
$2.61 B(+14.2%)
June 2023
-
$705.34 M(-0.7%)
$2.28 B(+10.0%)
Mar 2023
-
$709.96 M(+89.6%)
$2.07 B(+7.8%)
Dec 2022
$1.92 B(+6.5%)
$374.47 M(-23.7%)
$1.92 B(+1.7%)
Sept 2022
-
$491.03 M(-1.4%)
$1.89 B(+0.9%)
June 2022
-
$497.77 M(-11.0%)
$1.87 B(+2.5%)
Mar 2022
-
$559.51 M(+63.8%)
$1.83 B(+1.2%)
Dec 2021
$1.80 B(+7.0%)
$341.61 M(-28.0%)
$1.81 B(-4.7%)
Sept 2021
-
$474.51 M(+4.8%)
$1.89 B(+5.5%)
June 2021
-
$452.80 M(-15.7%)
$1.80 B(+2.3%)
Mar 2021
-
$537.39 M(+25.0%)
$1.76 B(+4.5%)
Dec 2020
$1.68 B(+17.0%)
$429.94 M(+14.4%)
$1.68 B(+5.0%)
Sept 2020
-
$375.92 M(-8.8%)
$1.60 B(+6.0%)
June 2020
-
$412.18 M(-10.6%)
$1.51 B(+1.9%)
Mar 2020
-
$461.20 M(+31.7%)
$1.48 B(+2.7%)
Dec 2019
$1.44 B(+1.1%)
$350.15 M(+22.9%)
$1.44 B(+4.6%)
Sept 2019
-
$284.98 M(-25.7%)
$1.38 B(-3.0%)
June 2019
-
$383.64 M(-9.2%)
$1.42 B(+2.8%)
Mar 2019
-
$422.64 M(+47.6%)
$1.38 B(-3.4%)
Dec 2018
$1.42 B(-11.4%)
$286.35 M(-12.6%)
$1.43 B(-5.3%)
Sept 2018
-
$327.63 M(-5.1%)
$1.51 B(-6.1%)
June 2018
-
$345.30 M(-26.8%)
$1.61 B(-3.2%)
Mar 2018
-
$471.49 M(+28.5%)
$1.66 B(+4.0%)
Dec 2017
$1.61 B(+9.4%)
$366.78 M(-13.8%)
$1.60 B(+2.7%)
Sept 2017
-
$425.43 M(+6.9%)
$1.56 B(+3.4%)
June 2017
-
$398.04 M(-2.4%)
$1.51 B(-0.1%)
Mar 2017
-
$408.00 M(+25.4%)
$1.51 B(+2.6%)
Dec 2016
$1.47 B(+14.4%)
$325.24 M(-13.2%)
$1.47 B(+1.6%)
Sept 2016
-
$374.57 M(-6.3%)
$1.45 B(+8.5%)
June 2016
-
$399.88 M(+8.3%)
$1.33 B(+5.8%)
Mar 2016
-
$369.33 M(+22.5%)
$1.26 B(-2.0%)
Dec 2015
$1.28 B(-5.5%)
$301.50 M(+15.5%)
$1.28 B(-0.3%)
Sept 2015
-
$261.06 M(-20.0%)
$1.29 B(-6.3%)
June 2015
-
$326.49 M(-17.4%)
$1.38 B(-2.8%)
Mar 2015
-
$395.16 M(+29.2%)
$1.42 B(+4.2%)
Dec 2014
$1.36 B(+3.7%)
$305.91 M(-12.0%)
$1.36 B(-0.8%)
Sept 2014
-
$347.46 M(-5.2%)
$1.37 B(+0.9%)
June 2014
-
$366.61 M(+8.4%)
$1.36 B(+1.9%)
Mar 2014
-
$338.33 M(+6.7%)
$1.33 B(+1.7%)
Dec 2013
$1.31 B(+18.9%)
$316.97 M(-5.3%)
$1.31 B(+1.7%)
Sept 2013
-
$334.81 M(-1.8%)
$1.29 B(+4.1%)
June 2013
-
$341.07 M(+7.8%)
$1.24 B(+5.6%)
Mar 2013
-
$316.24 M(+7.2%)
$1.17 B(+6.4%)
Dec 2012
$1.10 B(+22.1%)
$295.08 M(+3.9%)
$1.10 B(+9.1%)
Sept 2012
-
$284.05 M(+3.0%)
$1.01 B(+4.8%)
June 2012
-
$275.76 M(+12.3%)
$962.58 M(+4.1%)
Mar 2012
-
$245.63 M(+20.9%)
$924.97 M(+2.5%)
DateAnnualQuarterlyTTM
Dec 2011
$901.89 M(+30.5%)
$203.16 M(-14.7%)
$902.62 M(+7.8%)
Sept 2011
-
$238.04 M(-0.0%)
$837.68 M(+6.7%)
June 2011
-
$238.14 M(+6.7%)
$785.29 M(+7.8%)
Mar 2011
-
$223.28 M(+61.6%)
$728.24 M(+5.6%)
Dec 2010
$691.28 M(+14.7%)
$138.21 M(-25.6%)
$689.60 M(+0.8%)
Sept 2010
-
$185.66 M(+2.5%)
$684.14 M(+3.3%)
June 2010
-
$181.09 M(-1.9%)
$662.14 M(+2.7%)
Mar 2010
-
$184.64 M(+39.1%)
$644.46 M(+7.2%)
Dec 2009
$602.62 M(-0.0%)
$132.75 M(-18.9%)
$601.07 M(+0.1%)
Sept 2009
-
$163.66 M(+0.2%)
$600.76 M(-1.0%)
June 2009
-
$163.41 M(+15.7%)
$606.54 M(-0.1%)
Mar 2009
-
$141.25 M(+6.6%)
$606.95 M(+0.5%)
Dec 2008
$602.74 M(+33.5%)
$132.45 M(-21.8%)
$604.00 M(+10.9%)
Sept 2008
-
$169.44 M(+3.4%)
$544.60 M(+9.0%)
June 2008
-
$163.82 M(+18.5%)
$499.60 M(+6.3%)
Mar 2008
-
$138.30 M(+89.3%)
$470.15 M(+4.8%)
Dec 2007
$451.41 M(-1.2%)
$73.04 M(-41.3%)
$448.62 M(-9.1%)
Sept 2007
-
$124.44 M(-7.4%)
$493.77 M(-1.0%)
June 2007
-
$134.37 M(+15.1%)
$498.92 M(+1.7%)
Mar 2007
-
$116.77 M(-1.2%)
$490.53 M(+7.3%)
Dec 2006
$456.80 M(+15.7%)
$118.19 M(-8.8%)
$457.12 M(+9.9%)
Sept 2006
-
$129.59 M(+2.9%)
$416.13 M(+5.3%)
June 2006
-
$125.98 M(+51.1%)
$395.12 M(+3.8%)
Mar 2006
-
$83.36 M(+8.0%)
$380.48 M(-3.8%)
Dec 2005
$394.85 M(-4.0%)
$77.20 M(-28.9%)
$395.40 M(-10.0%)
Sept 2005
-
$108.58 M(-2.5%)
$439.42 M(+1.9%)
June 2005
-
$111.35 M(+13.3%)
$431.24 M(+2.1%)
Mar 2005
-
$98.27 M(-18.9%)
$422.54 M(+2.4%)
Dec 2004
$411.20 M(+6.7%)
$121.22 M(+20.7%)
$412.44 M(+41.6%)
Sept 2004
-
$100.41 M(-2.2%)
$291.22 M(+52.6%)
June 2004
-
$102.64 M(+16.4%)
$190.82 M(+116.4%)
Mar 2004
-
$88.17 M
$88.17 M
Dec 2003
$385.25 M(+37.5%)
-
-
Dec 2002
$280.10 M(+7.7%)
-
-
Dec 2001
$260.04 M(+19.4%)
-
-
Dec 2000
$217.73 M(+12.2%)
-
-
Dec 1999
$194.03 M(+12.0%)
-
-
Dec 1998
$173.25 M(+19.9%)
-
-
Dec 1997
$144.45 M(+15.2%)
-
-
Dec 1996
$125.36 M(+18.5%)
-
-
Dec 1995
$105.82 M(+34.3%)
-
-
Dec 1994
$78.78 M(+15.5%)
-
-
Dec 1993
$68.21 M(+2.7%)
-
-
Dec 1992
$66.44 M(-20.4%)
-
-
Dec 1991
$83.43 M(+36.3%)
-
-
Dec 1990
$61.19 M(+47.3%)
-
-
Dec 1989
$41.55 M(+4.4%)
-
-
Dec 1988
$39.81 M(+25.3%)
-
-
Dec 1987
$31.76 M(-4.1%)
-
-
Dec 1986
$33.13 M(+29.5%)
-
-
Dec 1985
$25.58 M(+13.9%)
-
-
Dec 1984
$22.46 M
-
-

FAQ

  • What is Novo Nordisk A/S annual income tax?
  • What is the all time high annual income tax for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual income tax year-on-year change?
  • What is Novo Nordisk A/S quarterly income tax?
  • What is the all time high quarterly income tax for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly income tax year-on-year change?
  • What is Novo Nordisk A/S TTM income tax?
  • What is the all time high TTM income tax for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM income tax year-on-year change?

What is Novo Nordisk A/S annual income tax?

The current annual income tax of NVO is $3.05 B

What is the all time high annual income tax for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual income tax is $3.05 B

What is Novo Nordisk A/S annual income tax year-on-year change?

Over the past year, NVO annual income tax has changed by +$1.13 B (+58.81%)

What is Novo Nordisk A/S quarterly income tax?

The current quarterly income tax of NVO is $1.04 B

What is the all time high quarterly income tax for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly income tax is $1.04 B

What is Novo Nordisk A/S quarterly income tax year-on-year change?

Over the past year, NVO quarterly income tax has changed by +$228.23 M (+27.98%)

What is Novo Nordisk A/S TTM income tax?

The current TTM income tax of NVO is $3.57 B

What is the all time high TTM income tax for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM income tax is $3.57 B

What is Novo Nordisk A/S TTM income tax year-on-year change?

Over the past year, NVO TTM income tax has changed by +$965.69 M (+37.07%)